EFFICACY OF MIRIKIZUMAB ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY

被引：0
|
作者：
Sandborn, William J.
Ferrante, Marc
Bhandari, Raj
D'Haens, Geert
Berliba, Elina
Feagan, Brian G.
Klekotka, Paul
Laskowski, Janelle
Durante, Michael
Tuttle, Jay L.
Naegeli, April
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P033
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF MIRIKIZUMAB ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY
    Sandborn, William J.
    Ferrante, Marc
    Bhandari, Raj
    D'Haens, Geert
    Berliba, Elina
    Feagan, Brian G.
    Klekotka, Paul
    Laskowski, Janelle
    Durante, Michael
    Tuttle, Jay L.
    Naegeli, April
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S16 - S16
  • [2] Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis
    Dubinsky, Marla C.
    Jairath, Vipul
    Feagan, Brian G.
    Naegeli, April N.
    Tuttle, Jay
    Morris, Nathan
    Shan, Mingyang
    Arora, Vipin
    Lissoos, Trevor
    Agada, Noah
    Hibi, Toshifumi
    Sands, Bruce E.
    BMJ OPEN GASTROENTEROLOGY, 2023, 10 (01):
  • [3] Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies
    Panes, Julian
    Vermeire, Severine
    Lindsay, James O.
    Sands, Bruce E.
    Su, Chinyu
    Friedman, Gary
    Zhang, Haiying
    Yarlas, Aaron
    Bayliss, Martha
    Maher, Stephen
    Cappelleri, Joseph C.
    Bushmakin, Andrew G.
    Rubin, David T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (02): : 145 - 156
  • [4] Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study
    Danese, S.
    Neurath, M.
    Kopon, A.
    Zakko, S.
    Simmons, T.
    Fogel, R.
    Maccarone, J.
    Zhan, X.
    Usiskin, K.
    Chitkara, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S4 - S5
  • [5] Health-related quality of life in Swedish patients with ulcerative colitis
    Hjortswang, H
    Ström, M
    Almer, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (11): : 2203 - 2211
  • [6] Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
    Sandborn, William J.
    Ferrante, Marc
    Bhandari, Bal R.
    Berliba, Elina
    Feagan, Brian G.
    Hibi, Toshifumi
    Tuttle, Jay L.
    Klekotka, Paul
    Friedrich, Stuart
    Durante, Michael
    Morgan-Cox, MaryAnn
    Laskowski, Janelle
    Schmitz, Jochen
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2020, 158 (03) : 537 - +
  • [7] IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A PHASE 2 STUDY ANALYSIS USING THE SF-36 V2 STANDARD
    Lichtenstein, Gary
    Feagan, Brian
    Tuttle, Jay
    Morris, Nathan
    Dong, Yan
    Arora, Vipin
    Naegeli, April
    Rubin, David
    GASTROENTEROLOGY, 2020, 158 (03) : S16 - S17
  • [8] IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A PHASE 2 STUDY ANALYSIS USING THE SF-36 V2 STANDARD
    Lichtenstein, Gary R.
    Feagan, Brian G.
    Tuttle, Jay
    Morris, Nathan
    Dong, Yan
    Arora, Vipin
    Naegeli, April N.
    Rubin, David T.
    GASTROENTEROLOGY, 2020, 158 (06) : S1204 - S1205
  • [9] IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A PHASE 2 STUDY ANALYSIS USING THE SF-36 V2 STANDARD
    Lichtenstein, Gary
    Feagan, Brian
    Tuttle, Jay
    Morris, Nathan
    Dong, Yan
    Arora, Vipin
    Naegeli, April
    Rubin, David
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S10 - S10
  • [10] Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
    Sanyal, A.
    Younossi, Z. M.
    Bass, N. M.
    Mullen, K. D.
    Poordad, F.
    Brown, R. S.
    Vemuru, R. P.
    Jamal, M. Mazen
    Huang, S.
    Merchant, K.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 853 - 861
12345